Trial Outcomes & Findings for Cough and Swallow Rehab Following Stroke (NCT NCT01907321)

NCT ID: NCT01907321

Last Updated: 2017-01-27

Results Overview

This measure will indicate if there are strength gains in the respiratory muscle by measuring expiratory pressure generating ability.

Recruitment status

COMPLETED

Study phase

PHASE1/PHASE2

Target enrollment

14 participants

Primary outcome timeframe

Change in baseline to week 7

Results posted on

2017-01-27

Participant Flow

Participants were only recruited for the EMST group. There was not a control arm. There were several reasons, including concern regarding recruitment which was painfully slow for this study. There is only 1 arm/group that completed the study.

See above statement. There was only the EMST group/arm recruited for this study.

Participant milestones

Participant milestones
Measure
Expiratory Muscle Strength Training (EMST)
Participants will complete 5 weeks of EMST training, 5 repetitions per set, 5 sets per day, 5 days per week. Expiratory muscle strength training: Small hand held device that provides calibrated (cmH20) resistance to expiratory pressure. Once sufficient pressure is achieved (participant blowing out into the device) a valve is released, enabling airflow. Measures performed on all subjects: Capsaicin is a cough-inducing vapor that will be inhaled by participants to induce coughing. The airflow of the cough will be recorded and measures of compression phase duration, peak expiratory flow rate, and post-peak plateau phase will be made. Pulmonary function test: Measures of forced vital capacity (FVC) and Forced expiratory volume in the 1st second (FEV1), and the ratio between the two measures (FEV1/FVC). Also included is the measure of maximum expiratory pressure. Airflow from the voluntary cough will also be recorded and measured using the spirometric system.
Overall Study
STARTED
14
Overall Study
COMPLETED
12
Overall Study
NOT COMPLETED
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Cough and Swallow Rehab Following Stroke

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Expiratory Muscle Strength Training (EMST)
n=14 Participants
Participants will complete 5 weeks of EMST training, 5 repetitions per set, 5 sets per day, 5 days per week. Expiratory muscle strength training: Small hand held device that provides calibrated (cmH20) resistance to expiratory pressure. Measures: Capsaicin will be used to induce coughing. The airflow of the cough will be recorded and measures of compression phase duration, and expiratory phase airflow will be made. Pulmonary function test: Measures of forced vital capacity (FVC) and Forced expiratory volume in the 1st second (FEV1), and the ratio between the two measures (FEV1/FVC). Airflow from the voluntary cough will also be recorded and measured using the spirometric system. These measures will be identical to those made on the capsaicin-induced cough. Fluoroscopic swallow study: Images from the swallow study will be used to determine the modified barium swallow impairment profile (MBSImp) score, as well as the penetration-aspiration score (PA).
Age, Continuous
64.5 years
n=5 Participants
Gender
Female
6 Participants
n=5 Participants
Gender
Male
8 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
5 Participants
n=5 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
Region of Enrollment
United States
14 participants
n=5 Participants
Maximum expiratory pressure
71.2 centimeters of water (Cm H2O)
STANDARD_DEVIATION 28.8 • n=5 Participants
Pulmonary function (FEV1/FVC)
.64 ratio (FEV1/FVC)
STANDARD_DEVIATION .20 • n=5 Participants
Penetration-aspiration score
1 Penetration-aspiration scale (1 is best)
n=5 Participants

PRIMARY outcome

Timeframe: Change in baseline to week 7

Population: Data from 14 adults with a history of ischemic stroke was analyzed for changes in maximum expiratory pressure generating capacity, cough strength, and swallowing safety. All but 2 participants (1 male, 1 female) completed the protocol. Intent to treat analysis was used.

This measure will indicate if there are strength gains in the respiratory muscle by measuring expiratory pressure generating ability.

Outcome measures

Outcome measures
Measure
Expiratory Muscle Strength Training (EMST)
n=14 Participants
Participants will complete 5 weeks of EMST training, 5 repetitions per set, 5 sets per day, 5 days per week. Expiratory muscle strength training: Small hand held device that provides calibrated (cmH20) resistance to expiratory pressure. Measures: Capsaicin will be used to induce coughing. The airflow of the cough will be recorded and measures of compression phase duration, and expiratory phase airflow will be made. Pulmonary function test: Measures of forced vital capacity (FVC) and Forced expiratory volume in the 1st second (FEV1), and the ratio between the two measures (FEV1/FVC). Airflow from the voluntary cough will also be recorded and measured using the spirometric system. These measures will be identical to those made on the capsaicin-induced cough. Fluoroscopic swallow study: Images from the swallow study will be used to determine the modified barium swallow impairment profile (MBSImp) score, as well as the penetration-aspiration score (PA).
Maximum Expiratory Pressure
104.31 cm H2O (pressure measurement)
Standard Deviation 70.1

SECONDARY outcome

Timeframe: Change in baseline to 7 weeks

Population: 14 adults with a history of ischemic stroke in the previous 2 years. All but two participants (1 male, 1 female) completed the protocol.

Cough airflow measure of peak expiratory flow rate

Outcome measures

Outcome measures
Measure
Expiratory Muscle Strength Training (EMST)
n=14 Participants
Participants will complete 5 weeks of EMST training, 5 repetitions per set, 5 sets per day, 5 days per week. Expiratory muscle strength training: Small hand held device that provides calibrated (cmH20) resistance to expiratory pressure. Measures: Capsaicin will be used to induce coughing. The airflow of the cough will be recorded and measures of compression phase duration, and expiratory phase airflow will be made. Pulmonary function test: Measures of forced vital capacity (FVC) and Forced expiratory volume in the 1st second (FEV1), and the ratio between the two measures (FEV1/FVC). Airflow from the voluntary cough will also be recorded and measured using the spirometric system. These measures will be identical to those made on the capsaicin-induced cough. Fluoroscopic swallow study: Images from the swallow study will be used to determine the modified barium swallow impairment profile (MBSImp) score, as well as the penetration-aspiration score (PA).
Cough Expiratory Airflow
2.43 Liters of air/second
Standard Deviation .95

Adverse Events

Expiratory Muscle Strength Training (EMST)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Karen Hegland, PI

University of Florida

Phone: 352 294-8366

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place